Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1276 AL 1290

Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome

Meijer L, Chrétien E, Ravel D.

J Alzheimers Dis. 2024;101(s1):S95-S113. doi: 10.3233/JAD-240078.

Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer's Disease

Zhang S, Crossley CA, Yuan Q.

Br J Biomed Sci. 2024 Oct 7;81:13169. doi: 10.3389/bjbs.2024.13169. eCollection 2024.

Comparative Diagnostic Performance of Amyloid-β Positron Emission Tomography and Magnetic Resonance Imaging in Alzheimer's Disease: A Head-to-Head Meta-Analysis

Li F, Cheng J, Jin K, Zhao L, Li J, Wu J, Ren X.

Brain Behav. 2024 Oct;14(10):e70111. doi: 10.1002/brb3.70111.

The unique role of anosognosia in the clinical progression of Alzheimer's disease: a disorder-network perspective

Andrade K, Pacella V.

Commun Biol. 2024 Oct 24;7(1):1384. doi: 10.1038/s42003-024-07076-7.

Association between glaucoma and the risk of Alzheimer's disease: A meta-analysis

Jiang M, Wang X, Liu Y, Li N, Jin W, Lu Y, Sun L.

Medicine (Baltimore). 2024 Oct 4;103(40):e39897. doi: 10.1097/MD.0000000000039897.

Perivascular space enlargement accelerates in ageing and Alzheimer's disease pathology: evidence from a three-year longitudinal multicentre study

Menze I, Bernal J, Kaya P, Aki Ç, Pfister M, Geisendörfer J, Yakupov R, Coello RD, Valdés-Hernández MDC, Heneka MT, Brosseron F, Schmid MC, Glanz W, Incesoy EI, Butryn M, Rostamzadeh A, Meiberth D, Peters O, Preis L, Lammerding D, Gref D, Priller J, Spruth EJ, Altenstein S, Lohse A, Hetzer S, Schneider A, Fliessbach K, Kimmich O, Vogt IR, Wiltfang J, Bartels C, Schott BH, Hansen N, Dechent P, Buerger K, Janowitz D, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Sanzenbacher C, Hinderer P, Scheffler K, Spottke A, Roy-Kluth N, Lüsebrink F, Neumann K, Wardlaw J, Jessen F, Schreiber S, Düzel E, Ziegler G.

Alzheimers Res Ther. 2024 Oct 31;16(1):242. doi: 10.1186/s13195-024-01603-8.

The role of exercise in the prevention and treatment of Alzheimer's disease and mild cognitive impairments

Brooks CD, Krishnamoorthy RR, Sumien N.

Ageing Res Rev. 2024 Dec;102:102555. doi: 10.1016/j.arr.2024.102555. Epub 2024 Oct 28.

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment

Lim AWY, Schneider L, Loy C.

Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.

Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder

Jain R, Chepke C, Davis LL, McIntyre RS, Raskind MA.

J Clin Psychiatry. 2024 Nov 8;85(4):plunaro2417ah. doi: 10.4088/JCP.plunaro2417ah.

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M.

J Alzheimers Dis. 2024 Nov;102(2):520-529. doi: 10.3233/JAD-240491. Epub 2024 Nov 13.

Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formation

Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy EI, Bernal J, Schütze H, Yakupov R, Peters O, Gref D, Schneider LS, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Rostamzadeh A, Glanz W, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Spottke A, Roy N, Heneka MT, Brosseron F, Wagner M, Wolfsgruber S, Dobisch L, Dechent P, Hetzer S, Scheffler K, Zeidman P, Stern Y, Schott BH, Jessen F, Düzel E, Maass A, Ziegler G; DELCODE study group.

Nat Commun. 2024 Nov 13;15(1):9815. doi: 10.1038/s41467-024-53360-9.

Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center

Shields LBE, Hust H, Cooley SD, Cooper GE, Hart RN, Dennis BC, Freeman SW, Cain JF, Shang WY, Wasz KM, Orr AT, Shields CB, Barve SS, Pugh KG.

J Prev Alzheimers Dis. 2024;11(6):1549-1562. doi: 10.14283/jpad.2024.159.

The Role of Epileptic Activity in Alzheimer's Disease

Chen TS, Lai MC, Hong WP, Huang CW.

Am J Alzheimers Dis Other Demen. 2024 Jan-Dec;39:15333175241303569. doi: 10.1177/15333175241303569.

Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

Schworer EK, Zammit MD, Wang J, Handen BL, Betthauser T, Laymon CM, Tudorascu DL, Cohen AD, Zaman SH, Ances BM, Mapstone M, Head E, Christian BT, Hartley SL; Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS).

Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.

Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets

Nakamura Y, Omori T, Nishiyama K, Ishikawa I, Aoki H, Nagakura N.

Alzheimer Dis Assoc Disord. 2024 Oct-Dec 01;38(4):351-357. doi: 10.1097/WAD.0000000000000648. Epub 2024 Nov 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias